LGVN Longeveron Inc. Insider Trading

Director Baluch Khoso buys 11,766 shares of LGVN; prior buys at this ticker showed 458.8% and 473.2% 30-day returns, but stock now -67.7% from 52-week high.

Baluch Khoso, a director, purchased 11,766 shares, increasing his holdings by 28.9% to 52,516 shares. His prior two purchases at LGVN (on 2023-12-29 and 2023-12-28) both demonstrated strong 30-day gains of 458.8% and 473.2% respectively, and each delivered positive 90-day returns (127.0% and 122.8%), establishing a pattern of well-timed entry points at this ticker. However, the current investment environment presents a starkly different backdrop: LGVN stock stands 67.7% below its 52-week high and has declined 39.4% over the past 30 days, while the company remains unprofitable with a net loss of $5.0M against quarterly revenue of only $316.0K. The substantial discount from prior highs and the director's history of successful timing at this ticker merit investor attention, but the company's deteriorating financial trajectory and depressed valuation warrant scrutiny of the underlying business health before any extrapolation from prior buy-side outcomes.

CFO Locklear buys 11,766 shares of LGVN at net cost $0.00; stock down 67.7% from 52-week high amid unprofitable operations.

Lisa Locklear, Chief Financial Officer, acquired 11,766 shares on 2025-08-11 at no apparent cost, increasing her holdings from 239,198 to 250,964 shares. The transaction occurs against a backdrop of severe stock deterioration: the current price of $0.86 sits 67.7% below the 52-week high of $2.66, and the stock has declined 39.4% over the prior 30 days. Fundamentally, Longeveron reported net income of $-5,028,000.00 on revenue of $316,000.00 in its latest quarter, highlighting persistent unprofitability. The zero-dollar purchase price suggests this acquisition may be grant-based (equity compensation or vesting) rather than an open-market discretionary buy, which limits its interpretive value as a conviction signal. Investors should note the company's severe operational challenges—negative earnings and minimal revenue—alongside the CFO's inability to purchase at market prices during a period of significant stock decline.